Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV

Background: Clinical trials and real-life studies have granted the efficacy and safety of dolutegravir and lamivudine (DTG/3TC) in naïve and experienced people living with HIV (PLWH), but there are no long-term data in elderly people. We herein describe our real-life cohort of PLWH who were ≥65 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzitelli, Maria, Sasset, Lolita, Gardin, Samuele, Leoni, Davide, Trunfio, Mattia, Scaglione, Vincenzo, Mengato, Daniele, Agostini, Elena, Vania, Eleonora, Putaggio, Cristina, Cattelan, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459453/
https://www.ncbi.nlm.nih.gov/pubmed/37632082
http://dx.doi.org/10.3390/v15081740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459453/
https://www.ncbi.nlm.nih.gov/pubmed/37632082
http://dx.doi.org/10.3390/v15081740

Ejemplares similares